Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1028

1.

Act1 is a negative regulator in T and B cells via direct inhibition of STAT3.

Zhang CJ, Wang C, Jiang M, Gu C, Xiao J, Chen X, Martin BN, Tang F, Yamamoto E, Xian Y, Wang H, Li F, Sartor RB, Smith H, Husni ME, Shi FD, Gao J, Carman J, Dongre A, McKarns SC, Coppieters K, Jørgensen TN, Leonard WJ, Li X.

Nat Commun. 2018 Jul 16;9(1):2745. doi: 10.1038/s41467-018-04974-3.

PMID:
30013031
2.

Coronary Plaque Characteristics in Patients With Diabetes Mellitus Who Presented With Acute Coronary Syndromes.

Sugiyama T, Yamamoto E, Bryniarski K, Xing L, Fracassi F, Lee H, Jang IK.

J Am Heart Assoc. 2018 Jul 13;7(14). pii: e009245. doi: 10.1161/JAHA.118.009245.

3.

Serum Potassium and Cardiovascular Events in Heart Failure with Preserved Left Ventricular Ejection Fraction Patients.

Nishihara T, Tokitsu T, Sueta D, Takae M, Oike F, Fujisue K, Usuku H, Takashio S, Hanatani S, Kanazawa H, Arima Y, Sakamoto K, Izumiya Y, Yamabe H, Kaikita K, Yamamoto E, Tsujita K.

Am J Hypertens. 2018 Jul 7. doi: 10.1093/ajh/hpy101. [Epub ahead of print]

PMID:
29985986
4.

Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.

Sugai T, Eizuka M, Fujita Y, Kawasaki K, Yamamoto E, Ishida K, Yamano H, Suzuki H, Matsumoto T.

Dig Dis Sci. 2018 Jul 5. doi: 10.1007/s10620-018-5167-4. [Epub ahead of print]

PMID:
29974407
5.

A combined fractional flow reserve and optical coherence tomography approach to guide coronary artery bypass grafting: A pilot study.

Fracassi F, Sugiyama T, Yamamoto E, Ghoshhajra B, Gin A, Albaghdadi M, Lee H, Melnitchouk S, Sundt TM, Jang IK.

J Thorac Cardiovasc Surg. 2018 Jun 2. pii: S0022-5223(18)31459-4. doi: 10.1016/j.jtcvs.2018.05.037. [Epub ahead of print] No abstract available.

PMID:
29960717
6.

Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.

Harada T, Yamamoto E, Yamano HO, Aoki H, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Eizuka M, Yorozu A, Sudo G, Kitajima H, Niinuma T, Kai M, Sasaki Y, Tokino T, Sugai T, Nakase H, Suzuki H.

J Gastroenterol. 2018 Jun 11. doi: 10.1007/s00535-018-1481-z. [Epub ahead of print]

PMID:
29948303
7.

Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.

Ito M, Yamabe H, Koyama J, Kanazawa H, Kaneko S, Kanemaru Y, Kiyama T, Arima Y, Takashio S, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Shono T, Utsunomiya D, Sasaki Y, Yamashita Y, Tsujita K.

J Cardiol. 2018 Jun 20. pii: S0914-5087(18)30144-8. doi: 10.1016/j.jjcc.2018.05.009. [Epub ahead of print]

PMID:
29935765
8.

Dengue fever during pregnancy.

Tien Dat T, Kotani T, Yamamoto E, Shibata K, Moriyama Y, Tsuda H, Yamashita M, Kajiyama H, Duc Thien Minh D, Quang Thanh L, Kikkawa F.

Nagoya J Med Sci. 2018 May;80(2):241-247. doi: 10.18999/nagjms.80.2.241.

9.

Waiting time in the outpatient clinic at a national hospital in Vietnam.

Thi Thao Nguyen S, Yamamoto E, Thi Ngoc Nguyen M, Bao Le H, Kariya T, Mon Saw Y, Duc Nguyen C, Hamajima N.

Nagoya J Med Sci. 2018 May;80(2):227-239. doi: 10.18999/nagjms.80.2.227.

10.

Enrichment of liposomal nanomedicines using monolithic solid phase extraction discs following preactivation with bivalent metal ion solutions.

Watanabe A, Karasawa K, Murayama S, Sano Y, Takagi M, Yamamoto E, Murata S, Kato M.

J Chromatogr A. 2018 Aug 24;1564:224-227. doi: 10.1016/j.chroma.2018.06.011. Epub 2018 Jun 5.

PMID:
29907411
11.

Atherosclerotic Coronary Plaque Development Visualized by In Vivo Coronary Imaging.

Sakamoto K, Nagamatsu S, Yamamoto E, Kaikita K, Tsujita K.

Circ J. 2018 Jun 25;82(7):1727-1734. doi: 10.1253/circj.CJ-18-0516. Epub 2018 Jun 13.

12.

Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers.

Sugai T, Eizuka M, Habano W, Fujita Y, Sato A, Sugimoto R, Otsuka K, Yamamoto E, Matsumoto T, Suzuki H.

Oncotarget. 2018 May 1;9(33):22895-22906. doi: 10.18632/oncotarget.25112. eCollection 2018 May 1.

13.

Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction - The CALDERA-GENE Study.

Kaikita K, Yoshimura H, Ishii M, Kudoh T, Yamada Y, Yamamoto E, Izumiya Y, Kojima S, Shimomura H, Tsunoda R, Matsui K, Ogawa H, Tsujita K; CALDERA-GENE Investigators.

Circ J. 2018 May 25;82(6):1517-1525. doi: 10.1253/circj.CJ-18-0197. Epub 2018 May 8.

14.

Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases - INVITATION trial.

Fujisue K, Shirakawa T, Nakamura S, Yamamoto N, Oshima S, Matsumura T, Tsunoda R, Hirai N, Tayama S, Nakamura N, Hirose T, Maruyama H, Fujimoto K, Kajiwara I, Sakamoto T, Nakao K, Sakaino N, Hokimoto S, Nagayoshi Y, Hokamaki J, Shimomura H, Sakamoto K, Yamamoto E, Izumiya Y, Kaikita K, Ogawa H, Tsujita K; INVITATION study investigators.

J Cardiol. 2018 May 4. pii: S0914-5087(18)30107-2. doi: 10.1016/j.jjcc.2018.03.012. [Epub ahead of print]

PMID:
29735336
15.

[Review of the Efficacy of Endoscopic Stenting for Malignant Colorectal Obstruction at Tokyo Metropolitan Ohtsuka Hospital].

Masuda T, Yabe S, Yamamoto E, Kobayashi K, Yoshimura T.

Gan To Kagaku Ryoho. 2018 Mar;45(3):554-556. Japanese.

PMID:
29650936
16.

Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease.

Hanatani S, Izumiya Y, Onoue Y, Tanaka T, Yamamoto M, Ishida T, Yamamura S, Kimura Y, Araki S, Arima Y, Nakamura T, Fujisue K, Takashio S, Sueta D, Sakamoto K, Yamamoto E, Kojima S, Kaikita K, Tsujita K.

Int J Cardiol. 2018 Apr 5. pii: S0167-5273(17)36483-5. doi: 10.1016/j.ijcard.2018.03.064. [Epub ahead of print]

PMID:
29650344
17.

Impact of Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions (from the Japanese Multicenter Registry).

Naganuma T, Tsujita K, Mitomo S, Ishiguro H, Basavarajaiah S, Sato K, Kobayashi T, Obata J, Nagamatsu S, Yamanaga K, Komura N, Sakamoto K, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Ogawa H, Nakamura S.

Am J Cardiol. 2018 Jun 15;121(12):1519-1523. doi: 10.1016/j.amjcard.2018.02.032. Epub 2018 Mar 13.

PMID:
29627112
18.

Factors associated with routine immunization coverage of children under one year old in Lao People's Democratic Republic.

Phoummalaysith B, Yamamoto E, Xeuatvongsa A, Louangpradith V, Keohavong B, Saw YM, Hamajima N.

Vaccine. 2018 May 3;36(19):2666-2672. doi: 10.1016/j.vaccine.2018.03.051. Epub 2018 Mar 30.

PMID:
29606518
19.

Estimated costs for treatment and prophylaxis of newborn vitamin K deficiency bleeding in Tashkent, Uzbekistan.

Tursunov D, Yoshida Y, Yrysov K, Sabirov D, Alimova K, Yamamoto E, Reyer JA, Hamajima N.

Nagoya J Med Sci. 2018 Feb;80(1):11-20. doi: 10.18999/nagjms.80.1.11.

20.

Evaluation of Collateral Source Characteristics With 3-Dimensional Analysis Using Micro-X-Ray Computed Tomography.

Arima Y, Hokimoto S, Tabata N, Nakagawa O, Oshima A, Matsumoto Y, Sato T, Mukunoki T, Otani J, Ishii M, Uchikawa M, Yamamoto E, Izumiya Y, Kaikita K, Ogawa H, Nishiyama K, Tsujita K.

J Am Heart Assoc. 2018 Mar 23;7(6). pii: e007800. doi: 10.1161/JAHA.117.007800.

21.

Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation.

Nishino K, Koda S, Kataoka N, Takamatsu S, Nakano M, Ikeda S, Kamamatsu Y, Morishita K, Moriwaki K, Eguchi H, Yamamoto E, Kikkawa F, Tomita Y, Kamada Y, Miyoshi E.

Oncotarget. 2018 Jan 29;9(16):12732-12744. doi: 10.18632/oncotarget.24332. eCollection 2018 Feb 27.

22.

Simulation of Stimuli-Responsive and Stoichiometrically Controlled Release Rate of Doxorubicin from Liposomes in Tumor Interstitial Fluid.

Yamamoto E, Hyodo K, Suzuki T, Ishihara H, Kikuchi H, Kato M.

Pharm Res. 2018 Mar 19;35(5):103. doi: 10.1007/s11095-018-2380-y.

PMID:
29557075
23.

Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas.

Nakamura K, Kajiyama H, Utsumi F, Suzuki S, Niimi K, Sekiya R, Sakata J, Yamamoto E, Shibata K, Kikkawa F.

Mol Clin Oncol. 2018 Mar;8(3):499-503. doi: 10.3892/mco.2018.1560. Epub 2018 Jan 19.

24.

Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.

Aoki H, Yamamoto E, Yamano HO, Sugai T, Kimura T, Tanaka Y, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Harada T, Sudo G, Eizuka M, Yorozu A, Kitajima H, Niinuma T, Kai M, Nojima M, Suzuki H, Nakase H.

Dig Dis Sci. 2018 Jul;63(7):1920-1928. doi: 10.1007/s10620-018-5016-5. Epub 2018 Mar 15.

PMID:
29546645
25.

Haplotype-based allele mining in the Japan-MAGIC rice population.

Ogawa D, Yamamoto E, Ohtani T, Kanno N, Tsunematsu H, Nonoue Y, Yano M, Yamamoto T, Yonemaru JI.

Sci Rep. 2018 Mar 12;8(1):4379. doi: 10.1038/s41598-018-22657-3.

26.

Utility of postural change in differentiating sludge from thrombus in the left atrial appendage: A case report.

Usuku H, Yamamoto E, Yoshimura H, Tsunoda R, Nishigami K, Nakajima M, Suzuki R, Tsujita K.

Echocardiography. 2018 Apr;35(4):573-574. doi: 10.1111/echo.13850. Epub 2018 Mar 5.

PMID:
29505659
27.

Thrombus resolution with tirofiban in the conservative management of patients presenting with plaque erosion.

Sugiyama T, Xing L, Yamamoto E, Fracassi F, Lee H, Yu B, Jang IK.

Coron Artery Dis. 2018 Jun;29(4):301-308. doi: 10.1097/MCA.0000000000000614.

PMID:
29494363
28.

Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.

Achey RL, Yamamoto E, Sexton D, Hammer C, Lee BS, Butler RS, Thompson NR, Nagel SJ, Machado AG, Lobel DA.

J Neurosurg. 2018 Feb 23:1-10. doi: 10.3171/2017.8.JNS1733. [Epub ahead of print]

PMID:
29473781
29.

Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status.

Sugai T, Eizuka M, Arakawa N, Osakabe M, Habano W, Fujita Y, Yamamoto E, Yamano H, Endoh M, Matsumoto T, Suzuki H.

Gastric Cancer. 2018 Feb 21. doi: 10.1007/s10120-018-0810-5. [Epub ahead of print]

PMID:
29468422
30.

Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation.

Koyama S, Fujita H, Shimosato T, Kamijo A, Ishiyama Y, Yamamoto E, Ishii Y, Hattori Y, Hagihara M, Yamazaki E, Tomita N, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT).

Probiotics Antimicrob Proteins. 2018 Feb 17. doi: 10.1007/s12602-018-9399-6. [Epub ahead of print]

PMID:
29455334
31.

Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial.

Kim-Mitsuyama S, Soejima H, Yasuda O, Node K, Jinnouchi H, Yamamoto E, Sekigami T, Ogawa H, Matsui K.

Sci Rep. 2018 Feb 16;8(1):3150. doi: 10.1038/s41598-018-20874-4.

32.

Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer.

Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yamano HO, Harada T, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Aoyama T, Eizuka M, Yorozu A, Kitajima H, Kai M, Sawada N, Sugai T, Nakase H, Suzuki H.

Oncotarget. 2017 Dec 20;9(4):4707-4721. doi: 10.18632/oncotarget.23523. eCollection 2018 Jan 12.

33.

Nonculprit Plaque Characteristics in Patients With Acute Coronary Syndrome Caused by Plaque Erosion vs Plaque Rupture: A 3-Vessel Optical Coherence Tomography Study.

Sugiyama T, Yamamoto E, Bryniarski K, Xing L, Lee H, Isobe M, Libby P, Jang IK.

JAMA Cardiol. 2018 Mar 1;3(3):207-214. doi: 10.1001/jamacardio.2017.5234.

PMID:
29417141
34.

A case of a rectal stricture related to ischemic proctitis following rupture of an aortic aneurysm.

Iida T, Ohkubo Y, Kubo T, Yamashita K, Onodera K, Yamamoto E, Nosho K, Ito T, Yamano H, Nakase H.

Endosc Int Open. 2018 Feb;6(2):E186-E189. doi: 10.1055/s-0043-117946. Epub 2018 Feb 1.

35.

[Surgical Treatment for Extremely Elderly Patients over 90 Years of Age with Stage IV Colorectal Cancer - A Report of Four Cases].

Yoshimura T, Yamamoto E, Yabe S, Masuda T, Sugimoto H, Koshiishi H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1656-1658. Japanese.

PMID:
29394733
36.

[A Case of Solitary Metastatic Diaphragmatic Tumor from Resected Rectal Cancer].

Yamamoto E, Yabe S, Hijikata K, Kobayashi K, Masuda T, Sugimoto H, Hoshino M, Goto H, Koshiishi H, Yoshimura T.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1361-1363. Review. Japanese.

PMID:
29394634
37.

The expression of Toll-like receptor 5 in preterm histologic chorioamnionitis.

Moroi H, Kotani T, Miki R, Tsuda H, Mizuno M, Ito Y, Ushida T, Imai K, Nakano T, Li H, Sumigama S, Yamamoto E, Iwase A, Kikkawa F.

J Clin Biochem Nutr. 2018 Jan;62(1):63-67. doi: 10.3164/jcbn.16-103. Epub 2017 Oct 11.

38.

[A Case of Endocrine Cell Carcinoma of the Transverse Colon with Very Poor Prognosis, Onset with Bowel Obstruction].

Yabe S, Yamamoto E, Masuda T, Sugimoto H, Koshiishi H, Yoshimura T.

Gan To Kagaku Ryoho. 2018 Jan;45(1):178-180. Japanese.

PMID:
29362347
39.

Hepatic portal venous gas due to polystyrene sulfonate-induced enteritis.

Kubo T, Yamashita K, Yokoyama Y, Hirayama D, Shirata T, Mitsuhashi K, Onodera K, Yamamoto E, Nosho K, Yamano H, Kubo T, Sugita S, Hasegawa T, Nakase H.

Clin J Gastroenterol. 2018 Jun;11(3):220-223. doi: 10.1007/s12328-018-0818-8. Epub 2018 Jan 22.

PMID:
29356959
40.

Detection of transition times from single-particle-tracking trajectories.

Akimoto T, Yamamoto E.

Phys Rev E. 2017 Nov;96(5-1):052138. doi: 10.1103/PhysRevE.96.052138. Epub 2017 Nov 28.

PMID:
29347678
41.

Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).

Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Int J Hematol. 2018 May;107(5):578-585. doi: 10.1007/s12185-017-2396-9. Epub 2018 Jan 5.

PMID:
29305770
42.

Origin of the blueshift of water molecules at interfaces of hydrophilic cyclic compounds.

Tomobe K, Yamamoto E, Kojić D, Sato Y, Yasui M, Yasuoka K.

Sci Adv. 2017 Dec 22;3(12):e1701400. doi: 10.1126/sciadv.1701400. eCollection 2017 Dec.

43.

A case of wild-type transthyretin amyloidosis associated with organizing pneumonia.

Nakao M, Muramatsu H, Yamamoto E, Suzuki Y, Arakawa S, Tomooka K, Sakai Y, Fujita K, Sato H.

J Rural Med. 2017 Nov;12(2):130-134. doi: 10.2185/jrm.2935. Epub 2017 Nov 30.

44.

EROSION Study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography-Based Management in Plaque Erosion): A 1-Year Follow-Up Report.

Xing L, Yamamoto E, Sugiyama T, Jia H, Ma L, Hu S, Wang C, Zhu Y, Li L, Xu M, Liu H, Bryniarski K, Hou J, Zhang S, Lee H, Yu B, Jang IK.

Circ Cardiovasc Interv. 2017 Dec;10(12). pii: e005860. doi: 10.1161/CIRCINTERVENTIONS.117.005860.

PMID:
29246916
45.

Pediatric-Onset Multiple Sclerosis: A Single Center Study.

Yamamoto E, Ginsberg M, Rensel M, Moodley M.

J Child Neurol. 2018 Jan;33(1):98-105. doi: 10.1177/0883073817739789.

PMID:
29246096
46.

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.

Sakata J, Utsumi F, Suzuki S, Niimi K, Yamamoto E, Shibata K, Senga T, Kikkawa F, Kajiyama H.

Oncotarget. 2017 Aug 10;8(59):99482-99494. doi: 10.18632/oncotarget.20107. eCollection 2017 Nov 21.

47.

Covariate balance for no confounding in the sufficient-cause model.

Suzuki E, Tsuda T, Yamamoto E.

Ann Epidemiol. 2018 Jan;28(1):48-53.e2. doi: 10.1016/j.annepidem.2017.11.005. Epub 2017 Nov 23.

PMID:
29241736
48.

Medical facility statistics in Japan.

Hamajima N, Sugimoto T, Hasebe R, Myat Cho S, Khaing M, Kariya T, Mon Saw Y, Yamamoto E.

Nagoya J Med Sci. 2017 Nov;79(4):515-525. doi: 10.18999/nagjms.79.4.515. Review.

49.

Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers.

Sugai T, Takahashi Y, Eizuka M, Sugimoto R, Fujita Y, Habano W, Otsuka K, Sasaki A, Yamamoto E, Matsumoto T, Suzuki H.

Mol Carcinog. 2018 Mar;57(3):451-461. doi: 10.1002/mc.22769. Epub 2017 Dec 23.

50.

Impact of current and past cancer history on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study.

Tabata N, Sueta D, Yamamoto E, Takashio S, Arima Y, Araki S, Yamanaga K, Ishii M, Sakamoto K, Kanazawa H, Fujisue K, Hanatani S, Soejima H, Hokimoto S, Izumiya Y, Kojima S, Yamabe H, Kaikita K, Tsujita K.

Eur Heart J Qual Care Clin Outcomes. 2017 Dec 1. doi: 10.1093/ehjqcco/qcx047. [Epub ahead of print]

PMID:
29211884

Supplemental Content

Loading ...
Support Center